IGM Biosciences Inc (IGMS)
7.60
+0.83
(+12.26%)
USD |
NASDAQ |
Apr 23, 15:29
IGM Biosciences Market Cap: 446.78M for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 397.99M |
| April 19, 2024 | 423.26M |
| April 18, 2024 | 435.61M |
| April 17, 2024 | 477.94M |
| April 16, 2024 | 540.84M |
| April 15, 2024 | 553.18M |
| April 12, 2024 | 538.49M |
| April 11, 2024 | 491.46M |
| April 10, 2024 | 480.87M |
| April 09, 2024 | 513.79M |
| April 08, 2024 | 514.97M |
| April 05, 2024 | 514.97M |
| April 04, 2024 | 522.61M |
| April 03, 2024 | 530.84M |
| April 02, 2024 | 537.31M |
| April 01, 2024 | 555.53M |
| March 28, 2024 | 567.29M |
| March 27, 2024 | 544.95M |
| March 26, 2024 | 510.27M |
| March 25, 2024 | 512.03M |
| March 22, 2024 | 604.91M |
| March 21, 2024 | 601.39M |
| March 20, 2024 | 579.64M |
| March 19, 2024 | 583.16M |
| March 18, 2024 | 613.73M |
| Date | Value |
|---|---|
| March 15, 2024 | 625.49M |
| March 14, 2024 | 599.62M |
| March 13, 2024 | 584.93M |
| March 12, 2024 | 584.93M |
| March 11, 2024 | 614.32M |
| March 08, 2024 | 735.42M |
| March 07, 2024 | 713.08M |
| March 06, 2024 | 718.37M |
| March 05, 2024 | 710.73M |
| March 04, 2024 | 720.14M |
| March 01, 2024 | 743.65M |
| February 29, 2024 | 741.14M |
| February 28, 2024 | 803.34M |
| February 27, 2024 | 833.86M |
| February 26, 2024 | 817.43M |
| February 23, 2024 | 759.33M |
| February 22, 2024 | 751.70M |
| February 21, 2024 | 792.19M |
| February 20, 2024 | 943.59M |
| February 16, 2024 | 1.019B |
| February 15, 2024 | 903.69M |
| February 14, 2024 | 877.28M |
| February 13, 2024 | 894.89M |
| February 12, 2024 | 1.016B |
| February 09, 2024 | 850.88M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
230.04M
Minimum
Oct 31 2023
3.876B
Maximum
Feb 09 2021
1.279B
Average
918.02M
Median
Dec 21 2021
Market Cap Benchmarks
| Inotiv Inc | 125.08M |
| Synlogic Inc | 22.25M |
| BioXcel Therapeutics Inc | 91.12M |
| Xilio Therapeutics Inc | 35.16M |
| NovaBay Pharmaceuticals Inc | 2.306M |
Market Cap Related Metrics
| PS Ratio | 186.50 |
| Price to Book Value | 2.198 |
| Price | 7.60 |
| Earnings Yield | -62.89% |